RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a pilot clinical trial to examine the safety and efficacy of TETRANITE^®, the company’s regenerative bone adhesive, to perform dental ridge augmentation procedures without the need for ancillary containment devices like membranes or meshes or fixation aids like tacks and screws.